Exelixis Inc (MIL:1EXEL)
€ 45.9 (0%) Market Cap: 11.64 Bil Enterprise Value: 11.06 Bil PE Ratio: 17.11 PB Ratio: 7.34 GF Score: 74/100

Exelixis Inc at Bernstein Strategic Decisions Conference Transcript

May 27, 2026 / 07:30PM GMT
Release Date Price: €43.6
Jeffrey Walch
Sanford C Bernstein & Co LLC - Equity analyst

Hi, my name is Jeffrey Walsh. I co-lead the US biotechnology coverage at Bernstein. Very excited today to have a nice fireside chat with Michael Morrissey, PhD, President, and Chief Executive Officer of Exalexis. Look forward to the conversation and thank you for attending.

Michael Morrissey
Exelixis Inc - President, Chief Executive Officer, Director

All right, great to be here. Thanks for the invitation.

Today and looking forward to we had a great day, looking forward to a great conversation.

Before I begin, let me just state that I'll be making forward-looking statements today, so people listening should see our SEC filings for a description of the risks that we face in our business.

Jeffrey Walch
Sanford C Bernstein & Co LLC - Equity analyst

That's perfect. And Michael, really appreciate you and the team coming out today. We've had you attend multiple of these conferences and really appreciate always hearing your story. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot